Welcome to the CCO Site

Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education. 

Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.

Submit

Audio on Respiratory Syncytial Virus in Older Adults: Understanding Risk, Diagnosis, and Evolving Prevention Strategies

In this on-demand recording of a live webinar, expert faculty discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults.
Spencer Durham Headshot
Spencer H. Durham, PharmD, BCPS, BCIDP
person default
Stefan Gravenstein, MD, MPH
Barbara Resnick, PhD, CRNP
Released: July 15, 2021

In this podcast, Spencer H. Durham, PharmD, BCPS, BCIDP; Stefan Gravenstein, MD, MPH; and Barbara Resnick, PhD, CRNP, discuss risk factors for respiratory syncytial virus among adults, the need for a vaccination strategy in this population, and the evolving clinical studies on vaccines for older adults. Following their dialogue, the faculty field questions from healthcare professionals.

Presenters:

Spencer H. Durham, PharmD, BCPS, BCIDP  
Associate Clinical Professor of Pharmacy Practice 
Director, Alumni & Professional Affairs Clinical Affairs & Outreach  
Auburn University Harrison School of Pharmacy  
Auburn, Alabama

Stefan Gravenstein, MD, MPH
Director
Division of Geriatrics and Palliative Medicine
The Warren Alpert Medical School of Brown University
Providence, Rhode Island

Barbara Resnick, PhD, CRNP
Professor
School of Nursing
University of Maryland
Nurse Practitioner
Roland Park Place
Baltimore, Maryland

Acknowledgements

This activity is provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Educational grant provided by:
Janssen Therapeutics, Division of Janssen Products, LP

Related Content

Prof. Sharon R. Lewin: expert insights on remdesivir for nonhospitalized adult and pediatric patients with COVID-19, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Prof. Sharon R. Lewin discusses ivermectin and the evolution of monoclonal antibody treatments during omicron, from Clinical Care Options (CCO)

Sharon R. Lewin, AO, FRACP, PhD, FAHMS Released: June 7, 2022

Dr Kristen Marks on COVID-19 second booster dose: indication, which vaccine, and timing, from Clinical Care Options (CCO)

Kristen Marks, MD Released: May 20, 2022

Expert commentary on new data in RSV epidemiology from ECCMID 2022, as reported by Clinical Care Options (CCO)

Ting Shi, PhD Released: May 19, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings